MESC for Competitors

Use medical-grade UV light to make air safe. We provide coronavirus disinfection and cleaning, and offer UV lights, robots, and HVAC sanitizing systems.

APEX is a patient-driven pharmaceutical company focused on optimizing the standard of mental health care with psilocybin by bringing data supported, clinically evaluated drugs to market for depression and anxiety in PTSD. Our strategy is focused on developing pharmaceutical products through a phased clinical program evaluating safety and efficacy across multiple indications, alongside a robust early access program. APEX has two GMP Certified drug assets. APEX-52 is microdose synthetic psilocybin for clinical evaluation, currently in active phase 2b trials, and APEX-25 is the company’s macro dose drug asset, developed for in-clinic dosing with assisted psychotherapy. APEX recently launched North America’s first take-home psilocybin trial, and received approval for the world’s largest psilocybin clinical trial to-date both evaluating APEX-52 in the treatment of anxiety and depression in diagnosed PTSD. APEX is driven by an experienced and passionate leadership team from the Veteran community, healthcare, drug policy and emerging sectors who want to make a difference and disrupt the $380+ billion global mental health market. Find out more at apexlabs.com

We pioneer the revolutionary and market-leading CellMaker airlift single-use disposable bioreactor systems and technology. Our innovative system delivers a unique way of aerating and mixing your process using airlift technology designed to improve and simplify your cell culture and fermentation processes. Choose from our Regular and Plus CellMaker Controllers available with 8L and 50L Enclosures. Our bioreactor systems are designed specifically to meet the challenges of the life sciences industry.